February 27th Options Now Available For Cardinal Health (CAH)

Cardinal Health (CAH) is presented as an options trade idea around the $207.39 stock price: selling-to-open the $205 put (bid $5.40) would set an effective purchase basis of $199.60 and is ~1% OTM with a 57% chance to expire worthless, implying a 2.63% return on cash (19.23% annualized). Alternatively, a covered-call using the $210 strike (bid $7.50) would produce a 4.87% total return to Feb. 27 if called, with a 51% chance to expire worthless and a 3.62% premium boost (26.40% annualized); implied vols are 27% (put) and 32% (call) versus a 26% trailing 12-month volatility.

Analysis

Market structure: The options setup around CAH (207.39) shows asymmetric retail/hedge demand — put IV 27% vs call IV 32% and short-term OTM strikes ~1% away. That structure benefits option sellers (collecting YieldBoosts of 2.63% on $205 put or 3.62% on $210 covered call to Feb-27), and hurts buyers who would pay elevated call IV if they need upside protection. Supply/demand implies modest near-term directional neutrality with slight skew to upside hedging (higher call IV) and limited expected move (~26% annualized realized vol), compressing premium relative to macro shock tails.

Risk assessment: Tail risks include large downside gaps from regulatory action, major distributor contract loss, or sudden credit tightening increasing working-capital costs — any could drop CAH >10-20% and force immediate option assignment. Short-term (days-weeks) option sellers face assignment and IV spikes around earnings/catalyst windows; medium term (months) funding and margin impact; long-term (quarters) operational shifts (e.g., reimbursement changes) affect valuation multiples. Hidden dependencies: early assignment risk around ex-dividend dates, liquidity/bid-ask spread risk in thin strikes, and correlation to healthcare services: a sector shock would overturn the short-premium bet.

Trade implications: Tactical: sell-to-open CAH Feb-27 $205 put at $5.40 if willing to own at $199.60 (implied 2.63% return / 19% annualized) — size 1–2% portfolio, max downside reserve = strike*shares. Alternative: buy CAH and sell $210 Feb-27 call to create covered call capturing 4.87% to assignment; consider buying a $195 protection put if net short risk >3%. Watch IV change: buy back or roll if IV rises +5 vol pts or stock gaps >4% intraday.

Contrarian angles: The marketplace underprices regulatory/contract risk — 57% expire-worthless odds on the $205 put may be optimistic if a 10%+ negative shock occurs; conversely, the high annualized YieldBoosts (>19%) signal mispriced short-term tail risk relative to Treasury yields (~5%). Historical parallels: distributor squeezes (e.g., contract losses) produced rapid >15% drawdowns despite stable realized vol beforehand. Unintended consequence: aggressive put-selling could result in concentrated long at a higher effective leverage if multiple contracts assign into a falling market.

Key Decisions for Investors

• Establish a sell-to-open position in CAH Feb-27 $205 put at $5.40 (effective basis $199.60) sized to 1–2% of portfolio capital; only if willing to own full position, and set max capital reserve = $205 * contracts * 100 to cover assignment.
• If owning CAH shares, sell-to-open Feb-27 $210 covered calls at $7.50 to capture 4.87% to assignment; limit covered-call allocation to 3% of portfolio and accept upside capping above $210 through expiry.
• Protect short-put or stock positions by buying a Feb-27 $195 put as a hedge if net exposure >2% of portfolio; cut hedge if realized IV compresses by >5 vol points or if CAH rallies >6% intraday.
• Avoid scaling beyond stated sizes ahead of CAH earnings or known catalysts (next 30–60 days); exit or roll positions if IV increases by +5 implied vol points or if CAH gaps through strike by >4% on first trading day after entry.
• Monitor three metrics daily for 30 days: CAH mid-IVs (trigger = +5 vol), stock price vs strike (trigger = 4% gap), and 10y Treasury yield (trigger = +50bp); adjust option exposures if any trigger is breached.